<?xml version="1.0" encoding="UTF-8"?>
<p id="p0215">A long-known effective compound against a variety of respiratory viruses and the resulting common cold is interferon alpha-2b, administered intranasally, before or shortly after exposure. However, due to its high cost, dosage frequency (six times daily), and side effects (mainly nasal irritation and bleeding) clinical application has been abandoned (
 <xref rid="bb0080" ref-type="bibr">Mossad, 1998</xref>).
</p>
